Alphadyne Asset Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.33M Buy
+3,439
New +$1.28M 0.01% 531
2026
Q1
Sell
-556
Closed -$195K 999
2025
Q4
$195K Buy
556
+540
+3,375% +$182K ﹤0.01% 732
2025
Q3
$5.17K Buy
+16
New +$4.98K ﹤0.01% 297
2018
Q1
Sell
-17,928
Closed -$4.03M 30
2017
Q4
$4.03M Buy
+17,928
New +$3.82M 0.52% 60

Other funds holding ELV

Alphadyne Asset Management's ELV Position: Q2 2026 in Review

Alphadyne Asset Management opened a new position in Elevance Health (ELV) in Q2 2026: 3,439 shares worth $1.33M. The stake represents 0.01% of the portfolio and ranks #531 among its holdings. This is a return to the name: Alphadyne Asset Management previously reported a position in ELV as recently as Q4 2025.

Alphadyne Asset Management first reported a position in ELV in Q4 2017 and has held it in 4 quarters since. The position peaked at $4.03M in Q4 2017. 1,607 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Alphadyne Asset Management held 3,439 shares of Elevance Health worth $1.33M as of Q2 2026.
  • Elevance Health was a new Alphadyne Asset Management position in Q2 2026.
  • Elevance Health made up 0.01% of Alphadyne Asset Management's portfolio in Q2 2026, its #531 holding.
  • Alphadyne Asset Management first reported a position in Elevance Health in Q4 2017 and has held it in 4 quarters since.
  • Alphadyne Asset Management's Elevance Health position peaked at $4.03M in Q4 2017.
  • 1,607 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Alphadyne Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.